HQL (abrdn Life Sciences Investors) Stock Analysis - Analyst Ratings
abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of May 21, 2026, HQL trades at $17.22 with a market cap of $537.31M and a P/E ratio of 0.00. HQL moved +1.41% today. Year to date, HQL is +6.90%; over the trailing twelve months it is +38.84%. Its 52-week range spans $10.55 to $18.46. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate HQL?
The average price target is $0.00.
HQL Key Metrics
Key financial metrics for HQL
Metric
Value
Price
$17.22
Market Cap
$537.31M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.56%
52-Week High
$18.46
52-Week Low
$10.55
Volume
202
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
HQL Analyst Consensus
HQL analyst coverage data. Average price target: $0.00.